Health Catalyst, Inc.

NasdaqGS:HCAT 株式レポート

時価総額：US$502.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Health Catalyst マネジメント

マネジメント 基準チェック /34

Health Catalyst'sの CEO はDan Burtonで、 Oct2012年に任命され、 の在任期間は 11.75年です。 は、会社の株式の1.45%を直接所有しており、その価値は$ 5.46M 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と7.2年です。

主要情報

Dan Burton

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間11.9yrs
CEOの所有権1.4%
経営陣の平均在職期間2yrs
取締役会の平均在任期間7.3yrs

経営陣の近況

Recent updates

Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets

Sep 24

Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business

Jul 17
Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business

Health Catalyst: Stellar Earnings Growth Projected

Jun 26

Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 12
Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Apr 04
Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible

Mar 09

Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)

Feb 16

Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

Jan 27
Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Dec 24
What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Dec 15
Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Oct 24
Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Jul 31
Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Jun 27
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Feb 22
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Dec 06
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Nov 03
Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate

Oct 14

Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer

Sep 07

CEO報酬分析

Health Catalyst の収益と比較して、Dan Burton の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$86m

Mar 31 2024n/an/a

-US$106m

Dec 31 2023n/an/a

-US$118m

Sep 30 2023n/an/a

-US$124m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$148m

Dec 31 2022US$4mUS$150k

-US$137m

Sep 30 2022n/an/a

-US$151m

Jun 30 2022n/an/a

-US$145m

Mar 31 2022n/an/a

-US$147m

Dec 31 2021US$6mUS$300k

-US$153m

Sep 30 2021n/an/a

-US$147m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$126m

Dec 31 2020US$5mUS$315k

-US$115m

Sep 30 2020n/an/a

-US$86m

Jun 30 2020n/an/a

-US$99m

Mar 31 2020n/an/a

-US$181m

Dec 31 2019US$4mUS$350k

-US$241m

Sep 30 2019n/an/a

-US$304m

Jun 30 2019n/an/a

-US$282m

Mar 31 2019n/an/a

-US$190m

Dec 31 2018US$5mUS$315k

-US$114m

報酬と市場: Danの 総報酬 がUS市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Danの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Dan Burton (49 yo)

11.9yrs

在職期間

Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Daniel Burton
CEO & Director11.9yrsデータなし1.43%
$ 7.2m
Jason Alger
Chief Financial Officerless than a yearUS$823.62k0.19%
$ 948.2k
Benjamin Landry
General Counsel & Secretary of the Board1.3yrsUS$946.31k0.17%
$ 838.8k
Linda Llewelyn
Chief People Officer6.6yrsUS$1.06m0.031%
$ 155.6k
Daniel LeSueur
Chief Operating Officerless than a yearデータなし0.069%
$ 346.3k
Dave Ross
Chief Technology Officer2yrsデータなしデータなし
Adam Brown
Senior Vice President of Investor Relations and Financial Planning & Analysis3.7yrsデータなしデータなし
Kyle Salyers
Chief Strategy Officer & Senior VP of Corporate Developmentno dataデータなしデータなし
Jeffrey Selander
Senior Vice President of International5.3yrsデータなしデータなし
Holly Rimmasch
Senior VP & Chief Clinical Officerno dataデータなしデータなし
Leslie Falk
Chief Client Success Officerno dataデータなしデータなし
Jason Jones
Chief Analytics Officer & Chief Data Science Officer1.7yrsデータなしデータなし

2.0yrs

平均在職期間

46yo

平均年齢

経験豊富な経営陣: HCATの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Daniel Burton
CEO & Director13yrsデータなし1.43%
$ 7.2m
John Kane
Independent Chairman8.6yrsUS$316.16k0.18%
$ 915.7k
Julie Larson-Green
Independent Director4.7yrsUS$233.49k0.077%
$ 385.4k
S. Smith
Independent Director4.7yrsUS$237.25k0.074%
$ 371.1k
Anita Pramoda
Independent Director8.4yrsUS$244.77k0.059%
$ 295.0k
Duncan Gallagher
Independent Director7.3yrsUS$244.77k0.093%
$ 466.4k
Matthew Kolb
Independent Director1.2yrsデータなしデータなし

7.3yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: HCATの 取締役会 は 経験豊富 であると考えられます ( 7.1年の平均在任期間)。